[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Anti-inflammatory Therapeutics Market Report 2017

July 2017 | 103 pages | ID: AD824087B7CEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Anti-inflammatory Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Anti-inflammatory Therapeutics for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Anti-inflammatory Therapeutics market competition by top manufacturers/players, with Anti-inflammatory Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AbbVie Inc.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • AstraZeneca PLC
  • Amgen Inc
  • Novartis AG
  • F. Hoffmann-La Roche AG
  • Eli Lily and Company
On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
  • Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
  • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
  • Corticosteroids
  • Biologics
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Anti-inflammatory Therapeutics for each application, includin
  • Arthritis
  • Psoriasis
  • Respiratory Disease
  • Multiple Sclerosis
  • Inflammatory Bowel Disease
  • Other Inflammatory Disease
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Anti-inflammatory Therapeutics Market Report 2017

1 ANTI-INFLAMMATORY THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Anti-inflammatory Therapeutics
1.2 Classification of Anti-inflammatory Therapeutics by Product Category
  1.2.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
  1.2.4 Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
  1.2.5 Corticosteroids
  1.2.6 Biologics
1.3 Asia-Pacific Anti-inflammatory Therapeutics Market by Application/End Users
  1.3.1 Asia-Pacific Anti-inflammatory Therapeutics Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Arthritis
  1.3.3 Psoriasis
  1.3.4 Respiratory Disease
  1.3.5 Multiple Sclerosis
  1.3.6 Inflammatory Bowel Disease
  1.3.7 Other Inflammatory Disease
1.4 Asia-Pacific Anti-inflammatory Therapeutics Market by Region
  1.4.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Anti-inflammatory Therapeutics (2012-2022)
  1.5.1 Asia-Pacific Anti-inflammatory Therapeutics Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Anti-inflammatory Therapeutics Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC ANTI-INFLAMMATORY THERAPEUTICS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Anti-inflammatory Therapeutics Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Anti-inflammatory Therapeutics Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Anti-inflammatory Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Anti-inflammatory Therapeutics (Volume and Value) by Type
  2.2.1 Asia-Pacific Anti-inflammatory Therapeutics Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Anti-inflammatory Therapeutics Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Anti-inflammatory Therapeutics (Volume) by Application
2.4 Asia-Pacific Anti-inflammatory Therapeutics (Volume and Value) by Region
  2.4.1 Asia-Pacific Anti-inflammatory Therapeutics Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Anti-inflammatory Therapeutics Revenue and Market Share by Region (2012-2017)

3 CHINA ANTI-INFLAMMATORY THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

3.1 China Anti-inflammatory Therapeutics Sales and Value (2012-2017)
  3.1.1 China Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Anti-inflammatory Therapeutics Revenue and Growth Rate (2012-2017)
  3.1.3 China Anti-inflammatory Therapeutics Sales Price Trend (2012-2017)
3.2 China Anti-inflammatory Therapeutics Sales Volume and Market Share by Type
3.3 China Anti-inflammatory Therapeutics Sales Volume and Market Share by Application

4 JAPAN ANTI-INFLAMMATORY THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Anti-inflammatory Therapeutics Sales and Value (2012-2017)
  4.1.1 Japan Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Anti-inflammatory Therapeutics Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Anti-inflammatory Therapeutics Sales Price Trend (2012-2017)
4.2 Japan Anti-inflammatory Therapeutics Sales Volume and Market Share by Type
4.3 Japan Anti-inflammatory Therapeutics Sales Volume and Market Share by Application

5 SOUTH KOREA ANTI-INFLAMMATORY THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Anti-inflammatory Therapeutics Sales and Value (2012-2017)
  5.1.1 South Korea Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Anti-inflammatory Therapeutics Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Anti-inflammatory Therapeutics Sales Price Trend (2012-2017)
5.2 South Korea Anti-inflammatory Therapeutics Sales Volume and Market Share by Type
5.3 South Korea Anti-inflammatory Therapeutics Sales Volume and Market Share by Application

6 TAIWAN ANTI-INFLAMMATORY THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Anti-inflammatory Therapeutics Sales and Value (2012-2017)
  6.1.1 Taiwan Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Anti-inflammatory Therapeutics Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Anti-inflammatory Therapeutics Sales Price Trend (2012-2017)
6.2 Taiwan Anti-inflammatory Therapeutics Sales Volume and Market Share by Type
6.3 Taiwan Anti-inflammatory Therapeutics Sales Volume and Market Share by Application

7 INDIA ANTI-INFLAMMATORY THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

7.1 India Anti-inflammatory Therapeutics Sales and Value (2012-2017)
  7.1.1 India Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Anti-inflammatory Therapeutics Revenue and Growth Rate (2012-2017)
  7.1.3 India Anti-inflammatory Therapeutics Sales Price Trend (2012-2017)
7.2 India Anti-inflammatory Therapeutics Sales Volume and Market Share by Type
7.3 India Anti-inflammatory Therapeutics Sales Volume and Market Share by Application

8 SOUTHEAST ASIA ANTI-INFLAMMATORY THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Anti-inflammatory Therapeutics Sales and Value (2012-2017)
  8.1.1 Southeast Asia Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Anti-inflammatory Therapeutics Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Anti-inflammatory Therapeutics Sales Price Trend (2012-2017)
8.2 Southeast Asia Anti-inflammatory Therapeutics Sales Volume and Market Share by Type
8.3 Southeast Asia Anti-inflammatory Therapeutics Sales Volume and Market Share by Application

9 AUSTRALIA ANTI-INFLAMMATORY THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Anti-inflammatory Therapeutics Sales and Value (2012-2017)
  9.1.1 Australia Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Anti-inflammatory Therapeutics Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Anti-inflammatory Therapeutics Sales Price Trend (2012-2017)
9.2 Australia Anti-inflammatory Therapeutics Sales Volume and Market Share by Type
9.3 Australia Anti-inflammatory Therapeutics Sales Volume and Market Share by Application

10 ASIA-PACIFIC ANTI-INFLAMMATORY THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 AbbVie Inc.
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Anti-inflammatory Therapeutics Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 AbbVie Inc. Anti-inflammatory Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Pfizer Inc.
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Anti-inflammatory Therapeutics Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Pfizer Inc. Anti-inflammatory Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Merck & Co., Inc.
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Anti-inflammatory Therapeutics Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Merck & Co., Inc. Anti-inflammatory Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Johnson & Johnson
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Anti-inflammatory Therapeutics Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Johnson & Johnson Anti-inflammatory Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 GlaxoSmithKline plc
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Anti-inflammatory Therapeutics Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 GlaxoSmithKline plc Anti-inflammatory Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 AstraZeneca PLC
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Anti-inflammatory Therapeutics Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 AstraZeneca PLC Anti-inflammatory Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Amgen Inc
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Anti-inflammatory Therapeutics Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Amgen Inc Anti-inflammatory Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Novartis AG
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Anti-inflammatory Therapeutics Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Novartis AG Anti-inflammatory Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 F. Hoffmann-La Roche AG
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Anti-inflammatory Therapeutics Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 F. Hoffmann-La Roche AG Anti-inflammatory Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Eli Lily and Company
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Anti-inflammatory Therapeutics Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Eli Lily and Company Anti-inflammatory Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview

11 ANTI-INFLAMMATORY THERAPEUTICS MANUFACTURING COST ANALYSIS

11.1 Anti-inflammatory Therapeutics Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Anti-inflammatory Therapeutics

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Anti-inflammatory Therapeutics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Anti-inflammatory Therapeutics Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC ANTI-INFLAMMATORY THERAPEUTICS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Anti-inflammatory Therapeutics Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Anti-inflammatory Therapeutics Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Anti-inflammatory Therapeutics Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Anti-inflammatory Therapeutics Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Anti-inflammatory Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Anti-inflammatory Therapeutics Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Anti-inflammatory Therapeutics Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Anti-inflammatory Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Anti-inflammatory Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Anti-inflammatory Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Anti-inflammatory Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Anti-inflammatory Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Anti-inflammatory Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Anti-inflammatory Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Anti-inflammatory Therapeutics Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Anti-inflammatory Therapeutics Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Anti-inflammatory Therapeutics Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Anti-inflammatory Therapeutics Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Anti-inflammatory Therapeutics Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Anti-inflammatory Therapeutics
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales Volume (K MT) by Type (2012-2022)
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Nonsteroidal Anti-inflammatory Diseases (NSAIDs) Product Picture
Figure Immune Selective Anti-inflammatory Derivatives (ImSAIDs) Product Picture
Figure Corticosteroids Product Picture
Figure Biologics Product Picture
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales (K MT) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Anti-inflammatory Therapeutics by Application in 2016
Figure Arthritis Examples
Table Key Downstream Customer in Arthritis
Figure Psoriasis Examples
Table Key Downstream Customer in Psoriasis
Figure Respiratory Disease Examples
Table Key Downstream Customer in Respiratory Disease
Figure Multiple Sclerosis Examples
Table Key Downstream Customer in Multiple Sclerosis
Figure Inflammatory Bowel Disease Examples
Table Key Downstream Customer in Inflammatory Bowel Disease
Figure Other Inflammatory Disease Examples
Table Key Downstream Customer in Other Inflammatory Disease
Figure Asia-Pacific Anti-inflammatory Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure China Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales Volume (K MT) and Growth Rate (2012-2022)
Figure Asia-Pacific Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Anti-inflammatory Therapeutics Market Major Players Product Sales Volume (K MT)(2012-2017)
Table Asia-Pacific Anti-inflammatory Therapeutics Sales (K MT) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Anti-inflammatory Therapeutics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Anti-inflammatory Therapeutics Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Anti-inflammatory Therapeutics Sales Share by Players/Suppliers
Figure Asia-Pacific Anti-inflammatory Therapeutics Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Anti-inflammatory Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Anti-inflammatory Therapeutics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Anti-inflammatory Therapeutics Revenue Share by Players
Figure 2017 Asia-Pacific Anti-inflammatory Therapeutics Revenue Share by Players
Table Asia-Pacific Anti-inflammatory Therapeutics Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Anti-inflammatory Therapeutics Sales Share by Type (2012-2017)
Figure Sales Market Share of Anti-inflammatory Therapeutics by Type (2012-2017)
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Anti-inflammatory Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Anti-inflammatory Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-inflammatory Therapeutics by Type (2012-2017)
Figure Asia-Pacific Anti-inflammatory Therapeutics Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Anti-inflammatory Therapeutics Sales Volume (K MT) and Market Share by Region (2012-2017)
Table Asia-Pacific Anti-inflammatory Therapeutics Sales Share by Region (2012-2017)
Figure Sales Market Share of Anti-inflammatory Therapeutics by Region (2012-2017)
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales Market Share by Region in 2016
Table Asia-Pacific Anti-inflammatory Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Anti-inflammatory Therapeutics Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Anti-inflammatory Therapeutics by Region (2012-2017)
Figure Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Region in 2016
Table Asia-Pacific Anti-inflammatory Therapeutics Sales Volume (K MT) and Market Share by Application (2012-2017)
Table Asia-Pacific Anti-inflammatory Therapeutics Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales Market Share by Application (2012-2017)
Figure China Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure China Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Anti-inflammatory Therapeutics Sales Price (USD/MT) Trend (2012-2017)
Table China Anti-inflammatory Therapeutics Sales Volume (K MT) by Type (2012-2017)
Table China Anti-inflammatory Therapeutics Sales Volume Market Share by Type (2012-2017)
Figure China Anti-inflammatory Therapeutics Sales Volume Market Share by Type in 2016
Table China Anti-inflammatory Therapeutics Sales Volume (K MT) by Applications (2012-2017)
Table China Anti-inflammatory Therapeutics Sales Volume Market Share by Application (2012-2017)
Figure China Anti-inflammatory Therapeutics Sales Volume Market Share by Application in 2016
Figure Japan Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure Japan Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Anti-inflammatory Therapeutics Sales Price (USD/MT) Trend (2012-2017)
Table Japan Anti-inflammatory Therapeutics Sales Volume (K MT) by Type (2012-2017)
Table Japan Anti-inflammatory Therapeutics Sales Volume Market Share by Type (2012-2017)
Figure Japan Anti-inflammatory Therapeutics Sales Volume Market Share by Type in 2016
Table Japan Anti-inflammatory Therapeutics Sales Volume (K MT) by Applications (2012-2017)
Table Japan Anti-inflammatory Therapeutics Sales Volume Market Share by Application (2012-2017)
Figure Japan Anti-inflammatory Therapeutics Sales Volume Market Share by Application in 2016
Figure South Korea Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure South Korea Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Anti-inflammatory Therapeutics Sales Price (USD/MT) Trend (2012-2017)
Table South Korea Anti-inflammatory Therapeutics Sales Volume (K MT) by Type (2012-2017)
Table South Korea Anti-inflammatory Therapeutics Sales Volume Market Share by Type (2012-2017)
Figure South Korea Anti-inflammatory Therapeutics Sales Volume Market Share by Type in 2016
Table South Korea Anti-inflammatory Therapeutics Sales Volume (K MT) by Applications (2012-2017)
Table South Korea Anti-inflammatory Therapeutics Sales Volume Market Share by Application (2012-2017)
Figure South Korea Anti-inflammatory Therapeutics Sales Volume Market Share by Application in 2016
Figure Taiwan Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure Taiwan Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Anti-inflammatory Therapeutics Sales Price (USD/MT) Trend (2012-2017)
Table Taiwan Anti-inflammatory Therapeutics Sales Volume (K MT) by Type (2012-2017)
Table Taiwan Anti-inflammatory Therapeutics Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Anti-inflammatory Therapeutics Sales Volume Market Share by Type in 2016
Table Taiwan Anti-inflammatory Therapeutics Sales Volume (K MT) by Applications (2012-2017)
Table Taiwan Anti-inflammatory Therapeutics Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Anti-inflammatory Therapeutics Sales Volume Market Share by Application in 2016
Figure India Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure India Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Anti-inflammatory Therapeutics Sales Price (USD/MT) Trend (2012-2017)
Table India Anti-inflammatory Therapeutics Sales Volume (K MT) by Type (2012-2017)
Table India Anti-inflammatory Therapeutics Sales Volume Market Share by Type (2012-2017)
Figure India Anti-inflammatory Therapeutics Sales Volume Market Share by Type in 2016
Table India Anti-inflammatory Therapeutics Sales Volume (K MT) by Application (2012-2017)
Table India Anti-inflammatory Therapeutics Sales Volume Market Share by Application (2012-2017)
Figure India Anti-inflammatory Therapeutics Sales Volume Market Share by Application in 2016
Figure Southeast Asia Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure Southeast Asia Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Anti-inflammatory Therapeutics Sales Price (USD/MT) Trend (2012-2017)
Table Southeast Asia Anti-inflammatory Therapeutics Sales Volume (K MT) by Type (2012-2017)
Table Southeast Asia Anti-inflammatory Therapeutics Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Anti-inflammatory Therapeutics Sales Volume Market Share by Type in 2016
Table Southeast Asia Anti-inflammatory Therapeutics Sales Volume (K MT) by Applications (2012-2017)
Table Southeast Asia Anti-inflammatory Therapeutics Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Anti-inflammatory Therapeutics Sales Volume Market Share by Application in 2016
Figure Australia Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure Australia Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Anti-inflammatory Therapeutics Sales Price (USD/MT) Trend (2012-2017)
Table Australia Anti-inflammatory Therapeutics Sales Volume (K MT) by Type (2012-2017)
Table Australia Anti-inflammatory Therapeutics Sales Volume Market Share by Type (2012-2017)
Figure Australia Anti-inflammatory Therapeutics Sales Volume Market Share by Type in 2016
Table Australia Anti-inflammatory Therapeutics Sales Volume (K MT) by Applications (2012-2017)
Table Australia Anti-inflammatory Therapeutics Sales Volume Market Share by Application (2012-2017)
Figure Australia Anti-inflammatory Therapeutics Sales Volume Market Share by Application in 2016
Table AbbVie Inc. Anti-inflammatory Therapeutics Basic Information List
Table AbbVie Inc. Anti-inflammatory Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AbbVie Inc. Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure AbbVie Inc. Anti-inflammatory Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure AbbVie Inc. Anti-inflammatory Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Inc. Anti-inflammatory Therapeutics Basic Information List
Table Pfizer Inc. Anti-inflammatory Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Inc. Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Inc. Anti-inflammatory Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Inc. Anti-inflammatory Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck & Co., Inc. Anti-inflammatory Therapeutics Basic Information List
Table Merck & Co., Inc. Anti-inflammatory Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure Merck & Co., Inc. Anti-inflammatory Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck & Co., Inc. Anti-inflammatory Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson & Johnson Anti-inflammatory Therapeutics Basic Information List
Table Johnson & Johnson Anti-inflammatory Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure Johnson & Johnson Anti-inflammatory Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson & Johnson Anti-inflammatory Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline plc Anti-inflammatory Therapeutics Basic Information List
Table GlaxoSmithKline plc Anti-inflammatory Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Anti-inflammatory Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline plc Anti-inflammatory Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table AstraZeneca PLC Anti-inflammatory Therapeutics Basic Information List
Table AstraZeneca PLC Anti-inflammatory Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AstraZeneca PLC Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure AstraZeneca PLC Anti-inflammatory Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure AstraZeneca PLC Anti-inflammatory Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table Amgen Inc Anti-inflammatory Therapeutics Basic Information List
Table Amgen Inc Anti-inflammatory Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Amgen Inc Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure Amgen Inc Anti-inflammatory Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure Amgen Inc Anti-inflammatory Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis AG Anti-inflammatory Therapeutics Basic Information List
Table Novartis AG Anti-inflammatory Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis AG Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure Novartis AG Anti-inflammatory Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis AG Anti-inflammatory Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table F. Hoffmann-La Roche AG Anti-inflammatory Therapeutics Basic Information List
Table F. Hoffmann-La Roche AG Anti-inflammatory Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Anti-inflammatory Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure F. Hoffmann-La Roche AG Anti-inflammatory Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table Eli Lily and Company Anti-inflammatory Therapeutics Basic Information List
Table Eli Lily and Company Anti-inflammatory Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eli Lily and Company Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate (2012-2017)
Figure Eli Lily and Company Anti-inflammatory Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure Eli Lily and Company Anti-inflammatory Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/MT) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-inflammatory Therapeutics
Figure Manufacturing Process Analysis of Anti-inflammatory Therapeutics
Figure Anti-inflammatory Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Anti-inflammatory Therapeutics Major Manufacturers in 2016
Table Major Buyers of Anti-inflammatory Therapeutics
Table Distributors/Traders List
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Anti-inflammatory Therapeutics Price (USD/MT) and Trend Forecast (2017-2022)
Table Asia-Pacific Anti-inflammatory Therapeutics Sales Volume (K MT) Forecast by Region (2017-2022)
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Anti-inflammatory Therapeutics Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share Forecast by Region in 2022
Figure China Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure China Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure South Korea Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Taiwan Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure India Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Australia Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Anti-inflammatory Therapeutics Sales (K MT) Forecast by Type (2017-2022)
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Anti-inflammatory Therapeutics Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Anti-inflammatory Therapeutics Price (USD/MT) Forecast by Type (2017-2022)
Table Asia-Pacific Anti-inflammatory Therapeutics Sales (K MT) Forecast by Application (2017-2022)
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories